Provided by Tiger Trade Technology Pte. Ltd.

Quince Therapeutics, Inc.

33.93
+1.825.67%
Post-market: 33.930.00000.00%19:30 EDT
Volume:10K
Turnover:317.02K
Market Cap:34.51M
PE:-0.37
High:34.09
Open:32.77
Low:32.57
Close:32.11
52wk High:909.98
52wk Low:15.10
Shares:1.02M
Float Shares:860.30K
Volume Ratio:0.34
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-90.9250
EPS(LYR):-335.2669
ROE:-153.84%
ROA:-31.51%
PB:-0.98
PE(LYR):-0.10

Loading ...

Craig-Hallum bullish on Quince Therapeutics, initiates with a Buy

TIPRANKS
·
Aug 20

Quince Therapeutics : Leerink Partners Adjusts Target Price to $68 from $4 to Reflect 1-for-20 Reverse Stock Split

THOMSON REUTERS
·
Aug 18

Quince Therapeutics Raises USD 115 Million in Private Placement of Series C Preferred Shares

Reuters
·
Aug 17

Quince Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Quince Therapeutics Q2 Net Loss Widens on Acquisition Charges

Reuters
·
Aug 14

Press Release: Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update

Dow Jones
·
Aug 14

Quince Therapeutics, Inc. Expected to Post a Loss of $17.88 a Share - Earnings Preview

Reuters
·
Aug 07

Quince Therapeutics - Brigette Roberts Conditionally Appointed as Chief Executive Officer - SEC Filing

THOMSON REUTERS
·
Aug 01

Quince Therapeutics Names Brigette Roberts CEO in Management Reshuffle

Reuters
·
Aug 01

Quince Therapeutics Announces Special Shareholder Meeting

Reuters
·
Aug 01

Quince Therapeutics - Offers 15,470,099 Shares of Common Stock for Resale - SEC Filing

THOMSON REUTERS
·
Aug 01

Analysts Offer Insights on Healthcare Companies: Quince Therapeutics (QNCX) and Opus Genetics (IRD)

TIPRANKS
·
Jul 31

Quince Therapeutics : Oppenheimer Initiates Coverage with Outperform Rating; Price Target $82

THOMSON REUTERS
·
Jul 29

Quince Therapeutics Appoints Paul Yu to Chair New Pulmonary Scientific Advisory Board

Reuters
·
Jun 30

Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board

THOMSON REUTERS
·
Jun 30

Take-Two, Quince, Tonix, CoreWeave, Affirm Trending With Analysts

TIPRANKS
·
Jun 27

Quince Therapeutics Amends 8-K to Correct Reverse Stock Split Description

Reuters
·
Jun 27

Quince Therapeutics files Form 3 for director, Chief Corporate Affairs Officer Brigette Roberts

Reuters
·
Jun 12

Quince Therapeutics shareholders approved reverse stock split authorization range of 1-for-10 to 1-for-100

Reuters
·
Jun 12

Quince Therapeutics regains Nasdaq listing compliance after equity rises to $15.67 million

Reuters
·
May 22